IRFAN DAHAR: Open Payments
NPI 1336101542 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,230 in 198 payments from 16 companies in 2025. Trend: 2023 $1,952 · 2024 $1,666 · 2025 $3,230
Food & beverage: $3,120Education: $109
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 54 | $823 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $428 |
| Vanda Pharmaceuticals Inc. | 21 | $396 |
| Teva Pharmaceuticals USA, Inc. | 16 | $373 |
| Lundbeck LLC | 19 | $274 |
| Alkermes, Inc. | 16 | $253 |
| Axsome Therapeutics, Inc. | 9 | $225 |
| E.R. Squibb & Sons, L.L.C. | 21 | $214 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| ABBVIE INC. | 2 | $46 |
Products named: REXULTI, CAPLYTA, HETLIOZ, ARISTADA, Auvelity, COBENFY, ABILIFY MAINTENA, UZEDY.
Industry payments across OH — which companies pay providers there.
